Current recommendation for atrial fibrillation patients undergoing ablation.

19 March 2019 (13:20 - 13:35)

Organised by:

About the speaker

Professor Jan Steffel

Klinik Hirslanden, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail

Welcome and Introduction - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Professor S. Hohnloser (Frankfurt, DE)

Presentation thumbnail

ELIMINATE-AF trial in the context of other non-vitamin K antagonist oral anticoagulant trials.

Professor J. Kautzner (Prague, CZ)

Presentation thumbnail

Implications of non-vitamin K antagonist oral anticoagulant trials in ablation practice.

Doctor M. Grimaldi (Acquaviva Delle Fonti, IT)

Presentation thumbnail

Panel discussion and closing remarks - Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

Professor S. Hohnloser (Frankfurt, DE)

Access the full session

Session thumbnail

Catheter ablation and anticoagulation in patients with Atrial Fibrillation (AF): where do we stand?

The Event

EHRA 2019

19 March 2019 13:20 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Presentation

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Session

Oral anticoagulation in subclinical atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources